Neoadjuvant treatment with weekly high-dose 5-fluorouracil as 24-hour infusion, folinic acid and oxaliplatin in patients with primary resectable liver metastases of colorectal cancer

Oncology

Volumn 64, Issue 2, 2003, Pages 131-138

  Wein, A ^a   Riedel, C ^a   Bruckl W ^a   Merkel, S ^a   Ott, R ^a   Hanke, B ^a   Baum, U ^a   Fuchs, F ^a   Gunther K ^a   Reck, T ^a   Papadopoulos, T ^a   Hahn, E G ^a   Hohenberger, W ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

5 Fluorouracil; Colorectal cancer; Folinic acid; Neoadjuvant treatment; Oxaliplatin; Resectable liver metastases; Weekly 24 hour infusion

Indexed keywords

FLUOROURACIL; FOLINATE CALCIUM; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONJUNCTIVITIS; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG INFUSION; DRUG TOLERABILITY; FEMALE; FEVER; FOLLOW UP; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPENIA; LIVER METASTASIS; MALE; METASTASIS; NAUSEA; OUTPATIENT; PAIN; PELVIC DISEASE; PERIPHERAL NEUROPATHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REMISSION; STOMATITIS; SURGICAL MORTALITY; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING; WOUND HEALING IMPAIRMENT;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0037256469     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067772     Document Type: Article

References (19)

1. McKean-Cowdin R, Feigelson SH, Ross RK, et al: Declining cancer rates in the 1990s. J Clin Oncol 2000;18:2258-2268.
2. Schmiegel W, Adler G, Frühmorgen P, et al: Kolorektales Karzinom: Prävention und Früherkennung in der asymptomatischen Bevölkerung - Vorsorge bei Risikopatienten - Endoskopische Diagnostik, Therapie und Nachsorge von Polypen und Karzinomen. Z Gastroenterol 2000;38:49-75.
3. Nordlinger B, Guiguet M, Vaillant J-C, et al: Surgical resection of colorectal carcinoma metastases to the liver. Cancer 1996;77:1254-1262.
4. Scheele J, Stangl R, Altendorf-Hofmann A, et al: Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
5. Fong Y, Cohen AM, Fortner JG, et al: Liver resection of colorectal metastases. J Clin Oncol 1997;15:938-946.
6. Fong Y, Fortner J, Sun RL, et al: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Ann Surg 1999;230:309-321.
7. Lorenz M, Müller H-H, Schramm H, et al: Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. Ann Surg 1998;228:756-762.
8. Kemeny N, Huang Y, Cohen AM, et al: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341:2039-2048.
9. Kemeny M, Sudeshna A, Gray B, et al: Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - An intergroup study. J Clin Oncol 2002;20:1499-1505.
10. De Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938-2947.
11. Giacchetti S, Perpoint B, Zidani R, et al: Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 2000;18:136-147.
12. Saltz LB, Cox JV, Blanke C, et al: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2000;343:905-914.
13. Douillard JY, Cunningham D, Roth AD, et al: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multi-centre randomised trial. Lancet 2000;355:1041-1047.
14. Wein A, Riedel C, Köckerling F, et al: Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-h infusion of high dose 5-fluorouracil and folinic acid. Ann Oncol 2001;12:1721-1727.
15. Giacchetti S, Itzhaki M, Gruia G, et al: Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999;10:663-669.
16. Bismuth H, Adam R, Lévi F, et al: Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-522.
17. World Health Organization: Handbook for Reporting Results of Cancer Treatment. Geneva, WHO, 1979, Publication No. 48.
18. Greenwood M: The natural duration of cancer. Reports on Public Health and Medical Subjects, 33. London, Her Majesty's Stationary Office, 1926.
19. Kronawitter U, Kemeny NE, Heelan R, et al: Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer 1999;86:229-235.